The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from PR Newswire

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing In Medtronic, Inc. To Contact The Firm

Monday, July 01, 2013

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing In Medtronic, Inc. To Contact The Firm

17:15 EDT Monday, July 01, 2013

NEW YORK, July 1, 2013 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Medtronic, Inc. ("Medtronic" or the "Company") (NYSE: MDT).

(Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO )

The investigation focuses on whether the Company and its executives violated federal securities laws with respect to its disclosures concerning business, operational, and compliance policies.  Specifically, the investigation focuses on whether Medtronic made false and misleading statements concerning the use of its INFUSE® Bone Graft ("Infuse") product in order to reduce pain and complications in connection with degenerative disc disease treatment.

After receiving an inquiry from the U.S. Senate regarding Infuse and the publication of The Spine Journal issue critical of Infuse, on August 3, 2011, the Company announced that it would not only release Infuse data to Yale University researchers, but that it would pay Yale $2.5 million to, among other things, create a database that could be used by the public to access information about Infuse.  Following this news and subsequent analyst reports, Medtronic's stock price dropped nearly 24% from its Class Period high

Request more information now by clicking here: www.faruqilaw.com/MDT.  There is no cost or obligation to you.

Take Action

If you invested in Medtronic's stock or options between December 8, 2010 and August 3, 2011 and would like to discuss your legal rights, visit www.faruqilaw.com/MDT.  You can also contact us by calling Richard Gonnello or Francis McConville toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com or fmcconville@faruqilaw.com.  Faruqi & Faruqi, LLP also encourages anyone with information regarding Medtronic's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising.  The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).  Prior results do not guarantee or predict a similar outcome with respect to any future matter.  We welcome the opportunity to discuss your particular case.  All communications will be treated in a confidential manner.

FARUQI & FARUQI, LLP369 Lexington Avenue, 10th FloorNew York, NY 10017Attn:  Richard Gonnello, Esq.  rgonnello@faruqilaw.com  Francis McConville, Esq.  fmcconville@faruqilaw.com  Telephone: (877) 247-4292 or (212) 983-9330

SOURCE Faruqi & Faruqi, LLP

Products
  • Globe Unlimited

    Digital all access pass across devices. subscribe

  • The Globe and Mail Newspaper

    Newspaper delivered to your doorstep. subscribe

  • Globe2Go

    The digital replica of our newspaper. subscribe

  • Globe eBooks

    A collection of articles by the Globe. subscribe

See all Globe Products

Advertise with us

GlobeLink.ca

Your number one partner for reaching Canada's Influential Achievers. learn more

The Globe at your Workplace
Our Company
Customer Service
Globe Recognition
Mobile Apps
NEWS APP
INVESTING APP
Other Sections